Robert Bailenson
Analyst · KBW. Please go ahead
Thank you, Dominic, and good morning to everyone on the call. I'm very pleased to report that our fourth quarter 2021 adjusted operating income was $273 million or $3.88 per share, a significant increase over the adjusted operating income of the fourth quarter of 2020, which was $56 million or $0.69 per share. The primary driver of the increase in fourth quarter 2021 total adjusted operating income was the insurance segment where adjusted operating income increased 154% over fourth quarter 2020 from $109 million to $277 million. Much of this benefit came from our loss mitigation strategies, particularly for our Puerto Rico exposure. After many years of negotiation, and other loss mitigation efforts, we are close to resolving $1.4 billion in gross par associated with our Puerto Rico GO, PBA, CCDA, and PREPA exposures. The increased certainty of the settlement in Puerto Rico is, improved economic output, combined with the increased value of our actual and expected recoveries under the settlement agreements, were the primary drivers of the $186 million economic benefit in the fourth quarter of 2021. During the fourth quarter of 2021, we sold a portion of our Salvage and Subrogation recoverables, associated with certain matured Puerto Rico GO and PREPA exposures, resulting in proceeds of $383 million, thereby realizing some of our expected recoveries early. In 2022 we continued to sell portions of our GO, PBA and PREPA Salvage and Subrogation recoverable, resulting in additional proceeds of $133 million. The prices at which we crystallized these recoveries as well as observed market pricing for other similar instruments, and the forward interest rate environment, are reflected in the updated assumptions of the value of the remaining recovery bonds, and contingent value instruments that we project receiving in the various Puerto Rico settlements. Other components of the insurance segment also performed well in the fourth quarter of 2021. Total income from investments, which consists of net investment income on the fixed maturity portfolio, and the equity and earnings on AssuredIM funds and other alternative investments, was $111 million and increased from $94 million in the fourth quarter of 2020. Collectively, the investments in AssuredIM funds and alternative investments generated $44 million in equity and earnings of investees in the fourth quarter of 2021, compared with $24 million in the fourth quarter of 2020, with the increase mainly attributable to a large fair value gain on a specific investment in a private equity fund. As a reminder, equity and earnings of investees is a function of mark to market movements attributable to the AssuredIM funds and other alternative investments. It is more volatile than the net investment income on the fixed maturity portfolio and will fluctuate from period to period. Our fixed maturity and short-term investments account for the largest portion of the portfolio, generating net investment income of $67 million in the fourth quarter of 2021, compared with $70 million in the fourth quarter of 2020. As we shift fixed maturity assets into alternative investments, net investment income from fixed maturities may decline. However, over the long term, we are targeting enhanced returns on the alternative investment portfolio of over 10%, which exceeds our projected returns on the fixed maturity portfolio. In terms of premiums scheduled net earned premiums decreased slightly in the fourth quarter of 2021 to $91 million, compared with fourth quarter 2020 of $94 million. Premium earnings due to refundings and terminations were $20 million in fourth quarter 2021 compared with $65 million in the fourth quarter of 2020 when two large transactions refunded. The Asset Management segment adjusted operating loss was $3 million dollars in the fourth quarter of 2021 compared with $20 million in the fourth quarter of 2020. The improvement in Asset Management segment results is primarily attributable to increased management fees and the strategies we launched since the 2019 BlueMountain acquisition and a nonrecurring impairment of the lease right-of-use asset of $13 million in 2020. Asset Management fees on a segment basis were $21 million in the fourth quarter of 2021 compared with $20 million in the fourth quarter of 2020. Higher fees from healthcare opportunity funds and CLOs more than offset the decrease in fees from wind-down funds as distributions to investors continued. As of December 31, 2021 AUM of the wind-down funds was $582 million, compared with $1.6 million as of December 31, 2020. In the fourth quarter of 2021, the effective tax rate was 15.1% compared with 12.7% in fourth quarter 2020, which included the release of a reserve for uncertain tax positions. The overall effective tax rate on adjusted operating income fluctuates period to period based on the proportion of income in different tax jurisdictions. Overall the fourth quarter capped off the year of successful execution of our strategic initiatives. These achievements are reflected in our 2021 full year adjusted operating income of $470 million, which includes a loss on extinguishment of debt of $175 million pre-tax or $138 million after tax. Despite the debt extinguishment charge, full year 2021 adjusted operating income represents an 84% increase compared with 2020 adjusted operating income of $256 million. The primary driver of this increase was the Insurance segment, with $722 million adjusted operating income in 2021, compared with $421 million in 2020. The 2021 Insurance segment adjusted operating income includes a benefit of $221 million, which primarily consists of a benefit of $146 million for U.S. public finance exposures and $84 million for U.S. RMBS exposures. U.S. public finance benefited from the increased recovery assumptions the Puerto Rico exposures that I mentioned earlier and the U.S. RMBs benefit is primarily a function of home price appreciation. Economic loss development, which excludes the effects of deferred premium revenue was a benefit of $287 million in 2021 across the whole portfolio. Loss expense in 2020 was $204 million and was primarily attributable to Puerto Rico. On a full year basis, total income from the investment portfolio was $424 million in 2021 compared with $371 million in 2020. The investment returns on a portion of the portfolio invested in AssuredIM funds demonstrates an important component of the benefits of the Asset Management segment, not only as a fee earning business, but as an investment advisor for our Insurance segment. AssuredIM funds in which the insurance subsidiaries invest, generated gains of $80 million in 2021 compared with gains of $42 million in 2020. The gains were across all strategies, particularly healthcare, CLOs and asset base, and generated a year-to-date return of 20.8%. Other third party alternative investments also generated gains of $64 million in 2021, compared with $19 million in 2020. These gains more than offset the reduced net investment income on the available to sell fixed maturity portfolio, which was $280 million in 2021, down from $310 million in 2020. Lower average balances in the fixed maturity portfolio, reinvestment yields, and income [ph] loss mitigation securities were the primary drivers of the year-over-year variance. Total minimum premiums in credit driven revenues were $438 [ph] million in 2021, compared with $504 million in 2020, including premium accelerations of $66 million and $130 million respectively. In the Asset Management segment, we have continued to make great progress in 2021. We raised new third party capital in our CLO, healthcare, and asset based strategies. We increase fee earning CLO AUM through the issuance of 2.8 billion in CLOs and the sale of CLO equity out of the legacy funds and we continue to liquidate assets and the wind-down funds. The improvement in the Asset Management segment operating loss from $50 million in 2020 to $90 million in 2021 was primarily attributable to an increase in management fees from $59 million in 2020 to $76 million in 2021. Higher fees from two CLOs and opportunity funds more than offset the decline in fees from wind-down funds. The increase in opportunity fund fees was primarily attributable to the new healthcare funds launched in late 2020, which raised additional third party capital in late 2021. The corporate division had adjusted operating loss of $263 million in 2021, including a loss on debt extinguishment of $175 million, or $138 million on an after tax basis, which resulted from a $600 million in debt redemptions that Dominic mentioned earlier. This charge is simply an acceleration of expenses that would have occurred over time. In the prior year, corporate division adjusted operating loss was $111 million. The debt redemptions were financed with the proceeds from the issuance of $900 million in new 10-year and 30-year debt, which resulted in reduced average coupon on redeemed debt from 5.89% to 3.35%, and $170 million debt reduction in our 2024 debt refinancing needs. In addition the debt refinancing has generated annual debt service savings of $5.2 million until the next maturity date, and provided flexibility to continue share repurchases. We were able to accomplish all of this without significantly affecting our debt leverage, or interest coverage ratios. The additional $300 million of proceeds for the debt expenses were used primarily for share repurchases. In the fourth quarter 2021 we repurchased 3.7 million shares for $192 million at an average price of $51.47 per share. This brings full year 2021 purchases to 10.5 million shares or $496 million, which represents 14% of the total shares outstanding at the beginning of the year. The continued success of this program helps to drive up per share book value metrics to record highs as of December 31, 2021. Subsequent to the quarter close, we repurchased an additional 1.7 million shares for $91 million. Since the beginning of our repurchase program in January 2013, we have returned $4.2 billion to shareholders under this program, resulting in a 69% reduction in total shares outstanding. The cumulative effect of these repurchases was a benefit of over $37 in adjusted operating shareholders equity per share and $65 in adjusted book value per share, which helped drive these metrics to new record highs. From a liquidity standpoint, the holding companies currently have cash and investments of approximately $274 million, of which $124 million resides in AGL. These funds are available for liquidity needs, or for use in the pursuit of our strategic initiatives to either expand our business or repurchase shares to manage our capital. This week, the Board of Directors authorized the repurchase of an additional 350 million of common shares. Under this and previous authorizations, the company is now authorized to purchase 364 million of its common shares. In addition, we declared a dividend of $0.27 per share, which represents an increase of 13.6% of the previous dividend of $0.22 per share. As we look to 2022 and beyond, we are optimistic that our largest single BIG exposure, Puerto Rico, will be substantially resolved by the end of this year. The interest rate environment will be more conducive to new insurance business production, and that the Asset Management segment and Alternative Asset strategies will continue to contribute to the company's progress towards its long-term strategic goals. I will now turn the call over to the operator to give you the instructions for our Q&A period. Thank you.